| _version_ | 1866902261240692736 |
|---|---|
| author | Muhammadieva, S.M. Abdusolieva, Z.T. Nabidzhonova, D.D. |
| author_facet | Muhammadieva, S.M. Abdusolieva, Z.T. Nabidzhonova, D.D. |
| contents | <p><strong><span>The purpose of our study </span></strong><span>was to evaluate the efficacy and safety of baricitinib (BARI) in patients with rheumatoid arthritis (RA) who have not achieved low activity or remission according to EULAR criteria under the influence of synthetic disease-modifying drugs or biological agents.</span></p> |
| format | Recurso digital |
| id | zenodo_https___doi_org_10_5281_zenodo_14964695 |
| institution | Zenodo |
| language | |
| publishDate | 2025 |
| publisher | Zenodo |
| record_format | zenodo |
| spellingShingle | EFFECTIVENESS OF BARICITINIB IN THE BASIC THERAPY OF ACTIVE RHEUMATOID ARTHRITIS Muhammadieva, S.M. Abdusolieva, Z.T. Nabidzhonova, D.D. <p><strong><span>The purpose of our study </span></strong><span>was to evaluate the efficacy and safety of baricitinib (BARI) in patients with rheumatoid arthritis (RA) who have not achieved low activity or remission according to EULAR criteria under the influence of synthetic disease-modifying drugs or biological agents.</span></p> |
| title | EFFECTIVENESS OF BARICITINIB IN THE BASIC THERAPY OF ACTIVE RHEUMATOID ARTHRITIS |
| url | https://doi.org/10.5281/zenodo.14964695 |